Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6Thoracic 5Plasma cell 4Endocrine 2CNS 2Other hematologic neoplasm 1NET 1Lymphoid 1Head & Neck 1Breast 1

Conditions

Neuroendocrine Tumors 32Gastro-enteropancreatic neuroendocrine tumor 6Carcinoid Tumor 4Adenoma, Islet Cell 3Serotonin Syndrome 2Parkinson Disease 2Neuroblastoma 2Neoplasms 2Congenital Hyperinsulinism 2Advanced Gastroenteropancreatic Neuroendocrine Tumor 2Thymus Neoplasms 1Pancreatic Neuroendocrine Tumors in MEN1 1Pancreatic Neuroendocrine Tumors (pNET) 1Non functioning pancreatic endocrine tumor 1Neuroendocrine Tumors in Lung 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms 1Lymphoma, Follicular 1Liposarcoma 1Lewy Body Disease 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Flushing 1Fibrosarcoma 1Disease 1Digestive Neuroendocrine Tumors 1Diarrhea 1Carcinoid Tumors, Intestinal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Disease × NET × Clear all
NCT00171873 2020-03-26

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut

Philipps University Marburg

Phase 3 Completed
85 enrolled 6 charts
EndocrineNET

Disease, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡